Company intelligence / Profile preview

PharmaKinetics Laboratories

Baltimore, Maryland, United States

Ownership: Private
Development stage: Other

Overview

PharmaKinetics Laboratories was a contract research organization (CRO) based in Baltimore, Maryland, that provided specialized clinical trial services to the pharmaceutical industry. The company's core expertise lay in pharmacokinetics, bioequivalence testing, and the management of Phase I-IV clinical trials. During its operational peak, PharmaKinetics was a publicly traded entity on the NASDAQ under the symbol PKLB. The firm served as a critical partner for drug developers seeking to understand the absorption, distribution, metabolism, and excretion of new therapeutic compounds. However, due to mounting debt and a challenging market environment, the company filed for Chapter 11 bankruptcy in 2002 and subsequently liquidated its assets.

Industry: Contract Research Organization

Beyond the preview

Go deeper on PharmaKinetics Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaKinetics Laboratories.

Explore the full profile